APS Sponsors
Who We Are
The Academy of Pharmaceutical Sciences (APS) is the UK-based professional membership body for Pharmaceutical Scientists.
We represent individuals and organisations from around the globe, throughout their development, in the delivery of excellence in the Pharmaceutical Science sector.
Pharmaceutical Scientists are experts in the research, development and manufacture of medicines. They have a major role in the regulation of medicines and understanding their use in patients.
What We Do
The APS is a not-for-profit organisation. We use revenues to champion innovation and opportunity in Pharmaceutical Sciences thereby improving the development and delivery of medicines for the benefit of patients. Our four key strategic themes, which are the foundation of all APS activities, are:
- Establish and promote the reputation of Pharmaceutical Sciences and Scientists
- Influence policy
- Further scientific knowledge
- Promote careers
APS Priorities
APS Chairs
For 25 years, the Academy of Pharmaceutical Scientists has been guided by exceptional Chairs whose leadership, vision, and dedication have shaped our community. Today we honour each of them for strengthening our mission, advancing scientific excellence, and leaving a legacy that continues to inspire future generations.
1 January 2026 – 31 December 2027
Dr Kofi Asare-Addo
Reader in Pharmaceutics, Admissions Tutor for Pharmacy (MPharm), University of Huddersfield
Kofi became a Fellow of the Higher Education Academy in 2014. His research area includes UV Imaging in pharmaceuticals, particle engineering, drug-clay complexations for oral controlled release formulation applications and solubility enhancements (solid dispersions, salts and cocrystals). His work has been presented both nationally and internationally at various pharmaceutical science conferences. Kofi successfully collaborates with other universities and several pharmaceutical industries.
1 January 2024 – 31 December 2025
Professor Ryan Donnelly
Chair in Pharmaceutical Technology, School of Pharmacy, Queen’s University Belfast
Professor Ryan Donnelly holds the Chair in Pharmaceutical Technology at Queen’s University Belfast and is Director of QUB’s interdisciplinary research programme Materials & Advanced Technologies for Healthcare (MATCH). His personal research is centred on design and physicochemical characterisation of advanced polymeric drug delivery systems for transdermal and intradermal drug delivery, with a strong emphasis on improving patient outcomes. He is currently developing a range of novel microneedle technologies through independent research, but also in collaboration with several major pharma partners.
He has obtained substantial UK Research Council, charity and industrial funding and authored over 300 peer-reviewed publications (H-index = 58), including 6 patent applications, 6 textbooks, 23 book chapters and approximately 250 full papers. He has been an invited speaker at numerous national and international conferences. Professor Donnelly is Europe/Africa Editor of Drug Delivery & Translational Research and the Controlled Release Society’s Communications Chair. He has won the Academy of Pharmaceutical Science’s Innovative Science Award (2020), Evonik’s Resomer Award (2018), the Controlled Release Society’s Young Investigator Award (2016), BBSRC Innovator of the Year and the American Association of Pharmaceutical Scientists Pharmaceutical Research Meritorious Manuscript Award (2013), the GSK Emerging Scientist Award (2012) and the Royal Pharmaceutical Society’s Science Award (2011).
1 January 2022 – 31 December 2023
Professor Hannah Batchelor
Professor of Biopharmaceutics, Strathclyde Institute of Pharmacy and Biomedical Sciences
Professor Hannah Batchelor specialises in developing medicines tailored to the needs of children, with a particular focus on age-appropriate formulations, biorelevant dissolution testing, and the application of cyber-physical systems to transform drug product development. Drawing on experience across academia, the NHS, and the pharmaceutical industry, her work bridges fundamental science with real-world patient needs. She is currently Professor at the Strathclyde Institute of Pharmacy and Biomedical Sciences, where she leads research on improving the design, manufacture, and performance prediction of paediatric medicines. Her contributions influence regulatory guidance, industrial practice, and global initiatives to enhance medicine acceptability and effectiveness for children.
“I really enjoyed getting the conferences back to in-person following COVID” – Hannah Batchelor